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Dear Editor, 
 
Tumor thickness is the most important prognostic factor in invasive melanoma (Balch et al, 
2001; Balch et al, 2009), and early detection has the potential to reduce both mortality and 
morbidity by diagnosing thinner melanomas. Full body skin examinations by physicians can 
facilitate early detection. 
 
Previous research has shown that patients with thin melanomas were more likely to report having 
clinician skin checks prior to their diagnosis (Geller et al, 1992; Geller et al, 2009a; Aitken et al, 
2010; Urech et al, 2016) . Notably, however, those studies relied on self-reports of skin checks 
after melanoma diagnosis, resulting in the potential for systematic recall bias as well as random 
misclassification. We sought to examine the relationship between physician skin checks and 
characteristics of melanoma cases diagnosed prospectively in a large population-based cohort.  
 
We included all incident melanoma diagnoses (invasive or in situ) arising in the QSkin Study 
cohort from recruitment in 2011 until 31 December 2014. The cohort includes men and women 
aged 40 through 69 years at recruitment who were sampled randomly from the Queensland 
population (n=43,794) (Olsen et al, 2012). Data on melanoma diagnoses were obtained from the 
Queensland Cancer Registry (melanoma notifications are mandatory). We obtained information 
about health service use during follow-up through linkage with Medicare, Australia’s universal 
health insurance scheme covering all age groups. The baseline survey asked “During the past 3 
years how many times has all or nearly all of your skin been deliberately checked by a Doctor?” 
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We used Cox proportional hazards models to compare the incidence of melanoma among 
participants grouped according to history of physician skin checks (categorized as 0, 1, 2+). We 
examined several outcomes: invasive (all, ≤1mm, >1mm); in situ; and all cutaneous melanomas 
(invasive + in situ). To examine characteristics of incident melanomas according to history of 
skin checks, we compared categorical variables using Pearson χ2 and/or Fisher exact test, and 
continuous variables using analysis of variance.  Full details of the cohort recruitment and 
statistical analyses are presented in Supplementary material (available online). The Human 
Research Ethics Committee at the QIMR Berghofer Medical Research Institute approved the 
study, and all participants gave written informed consent to take part. 
 
Of the entire cohort, 72% of participants reported having one or more skin checks in the 3 years 
prior to baseline. Over a median follow-up of 3.4 years (mean 3.5 years), 819 study participants 
developed melanoma. We excluded 164 (20%) participants who had a melanoma prior to 
baseline leaving 655 incident cases for analysis (invasive melanoma 251 cases; in situ melanoma 
404). The age-standardized (US 2000) invasive melanoma incidence rate was 153 per 100,000 
person-years. Of participants diagnosed with incident melanoma, 87% had reported having one 
or more physician skin checks in the 3 years prior to baseline (25% reported having one, 62% 
more than one). After adjustment for potentially confounding factors, relative to those with no 
history of physician skin checks in the three years prior to baseline, those who had such checks 
had a higher incidence of in situ and thin (≤1mm) but not thick (>1mm) invasive melanomas 
(Table 1).  
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Melanoma cases who reported having physician skin checks were more likely than other cases to 
have a high perceived likelihood of developing melanoma (p<0.001) and to have private health 
insurance (p=0.01) (Table 1). They were also more likely to have a higher number of visits to 
General Practitioners (GP) and dermatologists, higher number of skin biopsies and higher 
number of excisions for keratinocyte skin cancers (KC) during follow-up (up to 30 days prior to 
melanoma diagnosis) than other cases, although these were not statistically significant 
(Supplementary Table 1). There was no difference between cases who did and did not report skin 
checks in terms of their highest attained educational level, ethnicity, or phenotypic characteristics 
including skin color, eye color, hair color, skin phototype, freckling tendency, and moliness at 
age 21 (all p>0.10). We have previously described factors predicting skin examination practices 
in the full cohort (Olsen et al, 2015). 
 
The mean thickness of invasive melanomas amongst cases who reported having any skin checks 
was significantly lower than among those cases who had reported having none (0.78mm vs 1.39 
mm; p=0.005) (Table 2). Compared with cases who had reported no skin checks prior to 
baseline, those who reported one or more skin checks were more likely to have lentigo maligna 
(LM) subtype (Table 2). Mean thickness did not differ significantly according to number of skin 
biopsies, GP visits or excisions for KC during follow-up. We also examined the characteristics of 
melanoma cases and their first incident tumor amongst people who had reported one vs. two or 
more skin checks in the three years prior to baseline. We found no differences between these two 
groups for any characteristics, except number of dermatologist visits during follow-up, which 
increased with higher numbers of skin checks (p<0.001) (Supplementary Tables 2 and 3). 
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In our cohort, cases who had undergone any prior physician skin checks had thinner melanomas 
on average.  Other markers of health service use were not significantly associated with 
melanoma thickness. Our findings accord with previous research based on retrospective 
reporting of skin checks (Geller et al, 1992; Urech et al, 2016). 
 
Strengths of our study include the population-based sampling frame, prospective design leading 
to an absence of recall bias, and complete ascertainment of melanoma diagnoses (including in 
situ) during follow-up. We were also able to examine health service use during follow-up, as an 
adjunct to the self-reported information collected at baseline. Limitations include low response 
rate and reliance on self-report of prior physician skin checks.  
 
Knowledge of skin cancer risk factors in Queensland is very high and we have previously shown 
that people with high-risk phenotypes are more likely to undergo physician skin checks (Olsen et 
al, 2015). This aligns with other research suggesting that people who present for skin checks are 
more aware of their importance, and of the criteria to detect a lesion suspicious of melanoma 
(Geller et al, 2009b). Clinical skin examination appears to be increasing in the Queensland 
community as a result of greater awareness associated with the skin cancer prevention campaigns 
that began in the early 1980s (Marks, 1990).Our results may not generalize to other populations 
where awareness of risk factors and of the importance of seeking early medical attention for 
suspicious lesions is lower. Some may contend that our findings reflect over-diagnosis of 
indolent lesions (i.e. thinner lesions, and of the LM subtype) (Welch and Black, 2010), given the 
higher prevalence of screening behaviors amongst melanoma cases compared with non-cases 
(Olsen et al, 2015) and our finding that participants who reported skin checks had a higher 
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incidence of in situ and thin (≤1mm) but not thick (>1mm) invasive melanomas. Long-term 
follow-up of cases for progression and survival outcomes would be informative in this regard.  
 
In summary, our findings suggest that physician skin checks are widespread among melanoma 
cases and are associated with the detection of melanoma at its earliest stages.  
 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
7 
 
CONFLICT OF INTEREST 
DW: Grant funding received from National Health and Medical Research Council of Australia 
[APP1058522, APP1073898].  The remaining authors state no conflict of interest. 
 
ACKNOWLEDGEMENTS 
We thank Ms Carly Scott and Ms Peta Gordon at the Queensland Cancer Registry for their 
assistance with preparing the cancer data.  This work was supported in part by the National 
Health and Medical Research Council (NHMRC) of Australia (grant numbers 552429, 1073898). 
 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
8 
 
REFERENCES 
Aitken JF, Elwood M, Baade PD, Youl P, English D Clinical whole-body skin examination 
reduces the incidence of thick melanomas. Int J Cancer 2010;126:450-8. 
 
Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version 
of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;27:6199-206. 
 
Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. 
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint 
Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-34. 
 
Geller AC, Elwood M, Swetter SM, Brooks DR, Aitken J, Youl PH, et al. Factors related to the 
presentation of thin and thick nodular melanoma from a population-based cancer registry in 
Queensland Australia. Cancer 2009a;115:1318-27. 
 
Geller AC, Johnson TM, Miller DR, Brooks KR, Layton CJ, Swetter SM Factors associated with 
physician discovery of early melanoma in middle-aged and older men. Arch Dermatol 
2009b;145:409-14. 
 
Geller AC, Koh HK, Miller DR, Clapp RW, Mercer MB, Lew RA Use of health services before 
the diagnosis of melanoma: implications for early detection and screening. J Gen Intern Med 
1992;7:154-7. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
9 
 
 
Marks R Skin cancer control in the 1990's, from slip! Slop! Slap! To sun smart. Australas J 
Dermatol 1990;31:1-4. 
 
Olsen CM, Green AC, Neale RE, Webb PM, Cicero RA, Jackman LM, et al. Cohort profile: the 
QSkin Sun and Health Study. Int J Epidemiol 2012;41:929-i. 
 
Olsen CM, Thompson BS, Green AC, Neale RE, Whiteman DC, Sun QS, et al. Sun Protection 
and Skin Examination Practices in a Setting of High Ambient Solar Radiation: A Population-
Based Cohort Study. JAMA dermatology 2015;151:982-90. 
 
Urech M, Moscarella E, Lallas A, Ricci C, Longo C, Argenziano G Medical consultation the 
year before melanoma diagnosis: could we detect melanoma earlier? J Eur Acad Dermatol 
Venereol 2016;30:1065-6. 
 
Welch HG, Black WC Overdiagnosis in cancer. J Natl Cancer Inst 2010;102:605-13. 
 
 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
10 
 
Table 1. History of doctor skin checks and risk of invasive melanoma among 38,854 men and 
women in the QSkin study cohort.  
Number of skin checks by a doctor 
in the past 3 years 
Participants with melanoma  
No Yes  Multivariate model2 
n (%)1 n (%)1 P value HR (95%CI) 
     
All invasive melanoma     
 0 11,510 (28.6) 38 (14.9)  Reference 
 1 12,167 (30.2) 62 (24.3)  1.40 (0.93-2.11) 
 2 or more 16,585 (41.2) 155 (60.8) <0.001 2.01 (1.39-2.89) 
Invasive melanoma ≤1 mm     
 0 11,510 (28.6) 27 (13.3)  Reference 
 1 12,167 (30.2) 50 (24.6)  1.59 (0.99-2.55) 
 2 or more 16,585 (41.2) 126 (62.1) <0.001 2.36 (1.54-3.60) 
Invasive melanoma >1 mm     
 0 11,510 (28.6) 11 (22.9)  Reference 
 1 12,167 (30.2) 12 (25.0)  0.96 (0.41-2.23) 
 2 or more 16,585 (41.2) 25 (52.1)  0.31 0.98 (0.46-2.11) 
 
    
 
    
In situ  melanoma     
 0 11,465 (28.8) 49 (11.6)  Reference 
 1 12,063 (30.3) 110 (25.9)  2.00 (1.42-2.81) 
 2 or more 16,339 (41.0) 265 (62.5) <0.001 2.94 (2.14-4.03) 
     
     
All melanoma (invasive + in situ) 
    
 0 11,465 (28.8) 83 (12.8)  Reference 
 1 12,063 (30.3) 166 (25.4)  1.76 (1.35-2.31) 
 2 or more 16,339 (41.0) 401 (61.7) <0.001 2.55 (2.00-3.26) 
     
1
 Numbers may not sum to total due to missing data; six cases had an in situ melanoma diagnosed before an invasive melanoma. 
2 Adjusted for age, sex, tanning ability, hair color, moles at age 21, and family history of melanoma. 
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Table 2. Characteristics of first incident melanomas, stratified by self-reported history of having 
a skin check by a Doctor in the 3 years prior to baseline. 
Variables No skin check (n=83)  Skin check (n=567)  Chi-Square 
P value N (%)1 N (%)1 
Melanoma type 
 
 
 
In situ 45 (54.2) 356 (62.8)  
Invasive 38 (45.8) 211 (37.2) 0.13 
 
 
 
 
Invasive melanomas 
 
 
 
Age-standardized rate2  81.9/100,000 PY 182.3/100,000 PY  
 
 
 
 
Thickness 
 
 
 
Mean (SD) 1.39 (1.66) 0.78 (0.89) 0.0053 
Median (IQR) 0.71 (0.40-1.20) 0.50 (0.30-0.82) 0.0574 
 
   
≤0.5 mm 15 (39.5) 112 (54.6)  
0.51-1.00 mm 12 (31.6) 58 (28.3)  
1.01-1.99 mm 5 (13.2) 18 (8.8)  
2.00+ mm 6 (15.8) 17 (8.3) 0.25 
 
   
Melanoma type 
 
 
 
Superficial spreading 21 (55.3) 130 (61.6)  
Lentigo malignant 0 15 (7.1)  
Nodular 5 (13.2) 7 (3.3)  
Other 12 (31.6) 59 (28.0) 0.023 
 
 
 
 
All melanomas 
 
 
 
Age-standardized rate2  185.9/100,000 PY 485.9/100,000 PY  
 
 
 
 
Body site 
 
 
 
Head/neck 16 (19.3) 114 (20.1)  
Trunk 29 (34.9) 202 (35.6)  
Upper limbs 22 (26.5) 142 (25.0)  
Lower limbs 14 (16.9) 96 (16.9)  
Overlapping/NOS 2 (2.4) 13 (2.3) 0.99 
Melanoma type 
 
 
 
Superficial spreading 33 (39.8) 241 (42.5)  
Lentigo maligna/malignant 12 (14.5) 132 (23.3)  
Nodular 5 (6.0) 7 (1.2)  
Other 33 (39.8) 187 (33.0) 0.006 
 
 
 
 
1
 Numbers may not sum to total due to missing data; data is missing on skin checks by a doctor for 5 melanoma cases (2 invasive); thickness is 
missing for 6 invasive melanomas 
SD standard deviation; IQR inter-quartile range 
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2 
Standardised to US 2000 
3 
P-value for significant difference in mean values (Ryan-Einot-Gabriel-Welsch multiple range test) 
4 
P-value for significant difference in the median values (Wilcoxon rank sum test) 
